Attenuation and persistence of and ability to induce protective immunity to a Staphylococcus aureus aroA mutant in mice

Infection and Immunity

Volumn 74, Issue 6, 2006, Pages 3498-3506

  Buzzola, Fernanda R ^a   Barbagelata, María Sol ^a   Caccuri, Roberto L ^a   Sordelli, Daniel O ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; ERYTHROMYCIN; LIVE VACCINE; PHENYLALANINE; TRYPTOPHAN; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; AROA GENE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIUM TRANSFORMATION; CATTLE DISEASE; COLONY FORMING UNIT; CONTROLLED STUDY; DAIRY INDUSTRY; FEMALE; GENE INSERTION; GENE MUTATION; GENETIC COMPLEMENTATION; IMMUNITY; IMMUNIZATION; LETHAL DOSE; LUNG; MALE; MAMMARY GLAND; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; STAPHYLOCOCCUS AUREUS; START CODON; STARVATION; TRANSPOSON;

3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE; ANIMALS; DNA TRANSPOSABLE ELEMENTS; FEMALE; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MICE; MUTATION; RNA, MESSENGER; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; VACCINES, ATTENUATED;

EID: 33646911625     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01507-05     Document Type: Article

References (64)

1. Alexander, J. E., P. W. Andrew, D. Jones, and I. S. Roberts. 1993. Characterization of an aromatic amino acid-dependent Listeria monocytogenes mutant: attenuation, persistence, and ability to induce protective immunity in mice. Infect. Immun. 61:2245-2248.
2. Bentley, R. 1990. The shikimate pathway, a metabolic tree with many branches. Crit. Rev. Biochem. Mol. Biol. 25:307-384.
3. Bowe, F., P. O'Gaora, D. Maskell, M. Cafferkey, and G. Dougan. 1989. Virulence, persistence, and immunogenicity of of Yersinia enterocolitica O:8 aroA mutants. Infect. Immun. 57:3234-3236.
4. Brouillette, E., and F. Malouin. 2005. The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes Infect. 7:560-568.
5. Brown, F., G. Dougan, E. M. Hoey, S. J. Martin, B. K. Rima, and A. Trudgett. 1993. Vaccine design. John Wiley & Sons, Chichester, England.
6. Buzzola, F. R., L. Quelle, M. I. Gómez, M. Catalano, L. Steele-Moore, D. Berg, E. Gentilini, G. Denamiel, and D. O. Sordelli. 2001. Genotypic analysis of Staphylococcus aureus from milk of dairy cows with mastitis in Argentina. Epidemiol. Infect. 126:445-452.
7. Buzzola, F. R., L. S. Quelle, L. Steele-Moore, D. Berg, G. Denamiel, E. Gentilini, and D. O. Sordelli. 2001. Molecular diversity of live-attenuated prototypic vaccine strains and clinical isolates of Staphylococcus aureus. FEMS Microbiol. Lett. 202:91-95.
8. Carter, E. W., and D. E. Kerr. 2003. Optimization of DNA-based vaccination in cows using green fluorescent protein and protein A as a prelude to immunization against staphylococcal mastitis. J. Dairy Sci. 86:1177-1186.
9. Chamberlain, L. M., R. Strugnell, G. Dougan, C. E. Hormaeche, and R. Demarco de Hormaeche. 1993. Neisseria gonorrhoeae strain MS11 harbouring a mutation in gene aroA is attenuated and immunogenic. Microb. Pathog. 15:51-63.
10. Chandler, R. L. 1970. Experimental bacterial mastitis in the mouse. J. Med. Microbiol. 3:273-282.
11. Cheung, A. L., J. M. Koomey, C. A. Butler, S. J. Projan, and V. A. Fischetti. 1992. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc. Natl. Acad. Sci. USA 89:6462-6466.
12. Cheung, A. L., K. Eberhardt, and J. H. Heinrichs. 1997. Regulation of protein A synthesis by the sar and agr loci of Staphylococcus aureus. Infect. Immun. 65:2243-2249.
13. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
14. Crist, W. L., R. J. Harmon, J. O'Leary, and A. J. McAllister. 20 February 2006, posting date. Mastitis and its control. Cooperative Extension Service, University of Kentucky College of Agriculture. Publication ASC-140. [Online.] http://www.ca.uky.edu/agc/pubs/asc/asc140/asc140.pdf.
15. Dobinsky, S., K. Bartscht, and D. Mack. 2002. Influence of Tn917 insertion of transcription of the icaADBC operon in six biofilm-negative transposon mutants of Staphylococcus epidermidis. Plasmid 47:10-17.
16. Dougan, G., S. Chatfield, D. Pickard, J. Bester, D. O'Callaghan, and D. Maskell. 1988. Construction and characterization of vaccine strains of Salmonella harboring mutations in two different genes. J. Infect. Dis. 158:1329-1335.
17. Fetrow, J. 2000. Mastitis: an economic consideration, p. 3-47. In Proceedings of the 29th Annual Meeting of the National Mastitis Council, Atlanta, Ga. National Mastitis Council, Madison, Wis.
18. Finch, J. M., A. W. Hill, T. R. Field, and J. A. Leigh. 1994. Local vaccination with killed Streptococcus uberis protects the bovine mammary gland against experimental intramammary challenge with the homologous strain. Infect. Immun. 62:3599-3603.
19. Finch, J. M., A. Winter, A. W. Walton, and J. A. Leigh. 1997. Further studies on the efficacy of a live vaccine against mastitis caused by Streptococcus uberis. Vaccine 10:1138-1143.
20. Galas, D. J., and M. Chandler. 1989. Bacterial insertion sequences, p. 109-162. In E. B. Berg and M. M. Howe (ed.), Mobile DNA. American Society for Microbiology, Washington, D.C.
21. García, V. E., M. I. Gómez, M. F. Iglesias, N. Sanjuan, M. M. Gherardi, M. C. Cerquetti, and D. O. Sordelli. 1996. Intramammary immunization with live-attenuated Staphylococcus aureus: microbiological and immunological studies in a mouse mastitis model. FEMS Immunol. Med. Microbiol. 14:45-51.
22. Gómez, M. I., D. O. Sordelli, F. R. Buzzola, and V. E. García. 2002. Induction of cell-mediated immunity to Staphylococcus aureus in the mouse mammary gland by local immunization with a live attenuated mutant. Infect. Immun. 70:4254-4260.
23. Gómez, M. I., V. E. García, M. M. Gherardi, M. C. Cerquetti, and D. O. Sordelli. 1998. Intramammary immunizations with live-attenuated Staphylococcus aureus protects mice from experimental mastitis. FEMS Immunol. Med. Microbiol. 20:21-27.
24. Grüter, L., H. Feucht, M. Mempel, and R. Laufs. 1993. Construction of a slime negative transposon mutant in Staphylococcus epidermidis using the Enterococcus faecalis transposon Tn917. Microbiol. Immunol. 37:35-40.
25. Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
26. Homchampa, P., R. A. Strugnell, and B. Adler. 1992. Molecular analysis of the aroA gene of Pasteurella multocida and vaccine potential of constructed aroA mutants. Mol. Microbiol. 8:3585-3593.
27. -) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. Infect. Immun. 58:303-308.
28. Khal, B. C., M. Goulian, W. V. Wamel, M. Herrmann, S. M. Simon, G. Kaplan, G. Peters, and A. L. Cheung. 2000. Staphylococcus aureus RN6390 replicates and induces apoptosis in a pulmonary epithelial cell line. Infect. Immun. 68:5385-5392.
29. Leitner, G., E. Lubachevsky, E. Glikman, M. Winkler, A. Saran, and Z. Trainin. 2003. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. I. Field trial. Vet. Immunol. Immunopathol. 93:31-38.
30. Leitner, G., B. Yadlin, A. Glickman, M. Chaffer, and A. Saran. 2000. Systemic and local immune response of cows to intramammary infection with Staphylococcus aureus. Res. Vet. Sci. 69:181-184.
31. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
32. Maskell, D., K. J. Sweeney, D. O'Callaghan, C. E. Hormaeche, F. Y. Liew, and G. Dougan. 1987. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems. Microb. Pathog. 2:211-220.
33. Massey, R. C., A. Buckling, and S. J. Peacock. 2001. Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr. Biol. 11:1810-1814.
34. McArthur, J. D., N. P. West, J. N. Cole, H. Jungnitz, C. A. Guzman, J. Chin, P. R. Lehrbach, S. P. Djordjevic, and M. J. Walker. 2003. An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection. FEMS Microbiol. Lett. 221:7-16.
35. Mei, J., F. Nourbakhsh, C. Ford, and D. Holden. 1997. Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis. Mol. Microbiol. 26:399-407.
36. Michie, C. A. 2002. Staphylococcal vaccines. Trends Immunol. 23:461-463.
37. National Research Council. 1996. Guide for the care and use of laboratory animals (NIH guide, revised). National Academy Press, Washington, D.C.
38. O'Callaghan, D., D. Maskell, F. Y. Liew, C. S. F. Easmon, and G. Dougan. 1998. Characterization of aromatic- and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56:419-423.
39. O'Connell, C., P. Pattee, and T. J. Foster. 1993. Sequence and mapping of the aroA gene of Staphylococcus aureus 8325-4. J. Gen. Microbiol. 139:1449-1460.
40. Oyston, P. C. F., P. Russell, D. Williamson, and R. W. Titball. 1996. An aroA mutant of Yersinia pestis is attenuated in guinea-pigs, but virulent in mice. Microbiology 142:1847-1853.
41. Parish, T., and N. G. Stoker. 2002. The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis. Microbiology 148:3069-3077.
42. Patee, P. A., and S. Neveln. 1975. Transformation analysis of three linkage groups in Staphylococcus aureus. J. Bacteriol. 124:201-204.
43. Pitcher, D., N. Saundres, and R. Owen. 1989. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett. Appl. Microbiol. 8:151-153.
44. Priebe, G. P., M. M. Brinig, K. Hatano, M. Grout, F. T. Coleman, G. B. Pier, and J. B. Goldberg. 2002. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine. Infect. Immun. 70:1507-1517.
45. Proctor, R. A., O. Vesga, M. F. Otten, S. P. Koo, M. R. Yeamen, H. G. Sahl, and A. S. Bayer. 1996. Staphylococcus aureus small-colony variants cause persistent and resistant infections. Chemotherapy 42:47-52.
46. Raupach, B., and S. H. Kaufmann. 2001. Bacterial virulence, proinflammatory cytokines and host immunity: how to choose the appropriate Salmonella vaccine strain? Microbes Infect. 3:1261-1269.
47. Reed, L. J., and H. Muench. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27:493-491.
48. Riollet, C., P. Rainard, and B. Poutrel. 2000. Kinetics of cells and cytokines during immune-mediated inflammation in the mammary gland of cows systemically immunized with Staphylococcus aureus alpha-toxin. Inflamm. Res. 49:486-496.
49. Roberts, C. W., F. Roberts, R. E. Lyons, M. J. Kirisits, E. J. Mui, J. Finnerty, J. J. Johnson, D. J. Ferguson, J. R. Coggins, T. Krell, G. H. Coombs, W. K. Milhous, D. E. Kyle, S. Tzipori, J. Barnwell, J. B. Dame, J. Carlton, and R. McLeod. 2002. The shikimate pathway and its branches in apicomplexan parasites. J. Infect. Dis. 185(Suppl. 1):S25-S36.
50. Roberts, M., D. Maskell, P. Novotny, and G. Dougan. 1990. Construction and characterization in vivo of Bordetella pertussis aroA mutants. Infect. Immun. 58:732-739.
51. Sandman, K., R. Losick, and P. Youngman. 1987. Genetic analysis of Bacillus subtilis spo mutations generated by Tn917-mediated insertional mutagenesis. Genetics 117:603-617.
52. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
53. Simmons, C. P., A. L. M. Hodgson, and R. A. Strugnell. 1997. Attenuation and vaccine potential of aroQ mutants of Corynebacterium pseudotuberculosis. Infect. Immun. 65:3048-3056.
54. Sompolinsky, D., M. Cohen, and G. Ziv. 1974. Epidemiological and biochemical studies on thiamine-less dwarf-colony variants of Staphylococcus aureus as etiological agents of bovine mastitis. Infect. Immun. 9:217-228.
55. Sordelli, D. O., F. R. Buzzola, M. I. Gómez, L. Steele-Moore, D. Berg, E. Gentilini, M. Catalano, A. J. Reitz, T. Tollersrud, G. Denamiel, P. Jeric, and J. C. Lee. 2000. Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses. J. Clin. Microbiol. 38:846-850.
56. Sordillo, L. M., K. Shafer-Weaver, and D. DeRosa. 1997. Immunobiology of the mammary gland. J. Dairy Sci. 80:1851-1865.
57. Stritzker, J., J. Janda, C. Schoen, M. Taupp, S. Pilgrim, I. Gentschev, P. Schreier, G. Geginat, and W. Goebel. 2004. Growth, virulence, and immunogenicity of Listeria monocytogenes aro mutants. Infect. Immun. 72:5622-5629.
58. Tenhagen, B. A., D. Edinger, B. Baumgartner, P. Kalbe, G. Klunder, and W. Heuwieser. 2001. Efficacy of a herd-specific vaccine against Staphylococcus aureus to prevent post-partum mastitis in dairy heifers. J. Vet. Med. Ser. A 48:601-607.
59. Ulett, G. C., N. Ketheesan, and R. G. Hirst. 2000. Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei. Infect. Immun. 68:2034-2042.
60. Vaughn, L. M., P. R. Smith, and T. J. Foster. 1993. An aromatic-dependent mutant of the fish pathogen Aeromonas salmonicida is attenuated in fish and is effective as a live vaccine against the salmonid disease furunculosis. Infect. Immun. 61:2172-2182.
61. Waldvogel, F. A. 2000. Staphylococcus aureus, p. 2069-2092. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious disease. Churchill Livingstone, Philadelphia, Pa.
62. Walker, J. C., and N. K. Verma. 1997. Cloning and characterization of the aroA and aroD genes of Shigella dysenteriae type 1. Microbiol. Immunol. 41:809-813.
63. Yancey, R. J., Jr. 1999. Vaccines and diagnostic methods for bovine mastitis: fact and fiction. Adv. Vet. Med. 41:257-273.
64. Youngman, P. 1985. Plasmid vectors for recovering and exploiting Tn917 transpositions in Bacillus and other gram-positive bacteria, p. 79-104. In K. G. Hardy (ed.), Plasmids: a practical approach. IRL Press, Oxford, England.